MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Pioneers: Triple Helix: New Business Models_Open Innovation, Virtual Organizations, Royalty Aggregators, Etc.
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
*Industry: Massachusetts
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)
Organization & Developments: Concert Pharmaceuticals
Parents
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)
Children
2014: Concert Pharmaceuticals plans five drugs in human trials by end of 2014
2018: Concert Pharmaceuticals: Expecting Upside From Here_seekingalpha.com
2019: Concert Pharmaceuticals Could Have First Oral Drug For Patients With Sudden Hair Loss - Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)
2020: Biotech Analysis Central Preview Series: Concert Pharmaceuticals
2022: Concert Pharmaceuticals: A Speculative Buy For Their Alopecia Areata Drug_seekingalpha.com
Aims to improve upon approved or nearly-approved drugs by making them more molecularly stable
Jumps
*Key People: Concert Pharmaceuticals
Finance & Acquisitions: Concert Pharmaceuticals